• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON Back to Search Results
Model Number 97800
Device Problems Energy Output Problem (1431); Electromagnetic Compatibility Problem (2927)
Patient Problem Incontinence (1928)
Event Date 03/08/2024
Event Type  malfunction  
Event Description
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary/bowel dysfunction and urge incontinence.It was reported that since implant on (b)(6) 2023 and it helped by 50% or greater for their leakage but then on (b)(6) 2024, the patient had a total hip replacement and ever since the hip surgery, the patient didn't think it was working for their symptoms, because they were wet all the time and they would leak constantly, especially at night and if they stood up, they would gush.Patient stated that prior to the hip surgery, the orthopedic surgeon consulted with their urologist to make sure the surgery was successful.The patient stated they had a health care provider (hcp) appointment today however their hcp had told them if they needed assistance with their ins or therapy settings they should call "tech support." patient services reviewed the role of patient services and the health care provider (hcp) with the patient and provided the patient with the national answering services (nas) number for the hcp to page a medtronic representative if needed to check the patient's implanted system.Patient services r edirected the patient to follow up with the health care provider (hcp) to check the implanted system and reviewed programming considerations with the patient.The patient stated they would follow up with their health care provider (hcp) but wanted to try to make an increase to their stimulation with patient services in the meantime.The patient was already connected to their settings and the therapy was on.The patient then increased the stimulation to a comfortable level where the patient felt it in their bike-seat region.The patient was going to monitor their symptoms now that a change had been made and follow up with their health care provider (hcp) later today.They stated they may switch to another program if the increase did not help but noted they would monitor their symptoms in the meantime and give their body the chance to respond to the therapy increase first.Additional information was received from a healthcare professional (hcp).The hcp reported that the issue has not yet been resolved.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM X
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key19126923
MDR Text Key340405944
Report Number3004209178-2024-09260
Device Sequence Number1
Product Code EZW
UDI-Device Identifier00763000484668
UDI-Public00763000484668
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 05/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number97800
Device Catalogue Number97800
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/01/2024
Initial Date FDA Received04/17/2024
Supplement Dates Manufacturer Received05/06/2024
Supplement Dates FDA Received05/09/2024
Date Device Manufactured07/14/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age71 YR
Patient SexFemale
Patient Weight88 KG
-
-